 Rhabdomyosarcoma, Embryonal
"Rhabdomyosarcoma, Embryonal" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A form of RHABDOMYOSARCOMA arising primarily in the head and neck, especially the orbit, of children below the age of 10. The cells are smaller than those of other rhabdomyosarcomas and are of two basic cell types: spindle cells and round cells. This cancer is highly sensitive to chemotherapy and has a high cure rate with multi-modality therapy. (From Holland et al., Cancer Medicine, 3d ed, p2188)
| Descriptor ID |
D018233
|
| MeSH Number(s) |
C04.557.450.590.550.660.675 C04.557.450.795.550.660.675
|
| Concept/Terms |
Rhabdomyosarcoma, Embryonal- Rhabdomyosarcoma, Embryonal
- Embryonal Rhabdomyosarcoma
- Embryonal Rhabdomyosarcomas
- Rhabdomyosarcomas, Embryonal
|
Below are MeSH descriptors whose meaning is more general than "Rhabdomyosarcoma, Embryonal".
Below are MeSH descriptors whose meaning is more specific than "Rhabdomyosarcoma, Embryonal".
This graph shows the total number of publications written about "Rhabdomyosarcoma, Embryonal" by people in this website by year, and whether "Rhabdomyosarcoma, Embryonal" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2006 | 1 | 0 | 1 | | 2008 | 1 | 0 | 1 | | 2013 | 1 | 0 | 1 | | 2016 | 1 | 1 | 2 | | 2019 | 1 | 0 | 1 | | 2020 | 1 | 0 | 1 | | 2021 | 1 | 0 | 1 | | 2022 | 4 | 1 | 5 |
To return to the timeline, click here.
Below are the most recent publications written about "Rhabdomyosarcoma, Embryonal" by people in Profiles.
-
Patel AG, Chen X, Huang X, Clay MR, Komorova N, Krasin MJ, Pappo A, Tillman H, Orr BA, McEvoy J, Gordon B, Blankenship K, Reilly C, Zhou X, Norrie JL, Karlstrom A, Yu J, Wodarz D, Stewart E, Dyer MA. The myogenesis program drives clonal selection and drug resistance in rhabdomyosarcoma. Dev Cell. 2022 05 23; 57(10):1226-1240.e8.
-
Halstead NV, Mikkilineni N, Cost CR, Cost NG. Aggressive Multimodality Therapy for a Urachal Rhabdomyosarcoma. Urology. 2022 07; 165:e20-e24.
-
Whittle S, Venkatramani R, Sch?nstein A, Pack SD, Alaggio R, Vokuhl C, Rudzinski ER, Wulf AL, Zin A, Gruver JR, Arnold MA, Merks JHM, Hettmer S, Koscielniak E, Barr FG, Hawkins DS, Bisogno G, Sparber-Sauer M. Congenital spindle cell rhabdomyosarcoma: An international cooperative analysis. Eur J Cancer. 2022 06; 168:56-64.
-
Davies OMT, Bruckner AL, McCalmont T, Mascarenhas L, Oza V, Williams ML, Wine-Lee L, Shern JF, Siegel DH. Cutaneous mosaic RASopathies associated with rhabdomyosarcoma. Pediatr Blood Cancer. 2022 05; 69(5):e29639.
-
Hsu JY, Danis EP, Nance S, O'Brien JH, Gustafson AL, Wessells VM, Goodspeed AE, Talbot JC, Amacher SL, Jedlicka P, Black JC, Costello JC, Durbin AD, Artinger KB, Ford HL. SIX1 reprograms myogenic transcription factors to maintain the rhabdomyosarcoma undifferentiated state. Cell Rep. 2022 02 01; 38(5):110323.
-
Ahmed AA, Habeebu S, Farooqi MS, Gamis AS, Gonzalez E, Flatt T, Sherman A, Surrey L, Arnold MA, Conces M, Koo S, Dioufa N, Barr FG, Tsokos MG. MYOD1 as a prognostic indicator in rhabdomyosarcoma. Pediatr Blood Cancer. 2021 09; 68(9):e29085.
-
Koo J, Garrington TP, Kerr K, Treece AL, Cost CR. Pediatric ovarian Sertoli-Leydig cell tumors with heterologous rhabdomyosarcoma elements: Clinical case series and review of the literature. Pediatr Blood Cancer. 2020 10; 67(10):e28621.
-
Halstead NV, Cost NG, Hecht SL, Walker JP. Neurofibromatosis-1 and Rhabdomyosarcoma: An Unusual Recurrence. Urology. 2020 Mar; 137:168-172.
-
King MT, Voros L, Cohen GN, Lanning RM, Ganly I, O'Suoji CC, Wolden SL. High-dose-rate brachytherapy of rhabdomyosarcoma limited to the external auditory canal. Brachytherapy. 2017 Jan - Feb; 16(1):181-185.
-
Arnold MA, Anderson JR, Gastier-Foster JM, Barr FG, Skapek SX, Hawkins DS, Raney RB, Parham DM, Teot LA, Rudzinski ER, Walterhouse DO. Histology, Fusion Status, and Outcome in Alveolar Rhabdomyosarcoma With Low-Risk Clinical Features: A Report From the Children's Oncology Group. Pediatr Blood Cancer. 2016 Apr; 63(4):634-9.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|